Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
10.1007/s00223-001-1091-1 92
Key Features High-purity lyophilized peptide Batch-specific Certificate of Analysis included Manufactured under strict quality standards Suitable for controlled laboratory research Packaged for professional handling environments Technical Specifications Compound: BPC-157 Format: Lyophilized powder Strength: 10 mg per vial Purity: 9899% (COA included) Appearance: White powder Category: Research peptide reagent Intended Use This product is intended strictly for: Laboratory research In-vitro studies Biochemical analysis Preclinical model research Not intended for: Human or animal use Injection, ingestion, inhalation, or topical application Medical, therapeutic, diagnostic, or cosmetic purposes This compound is not approved by Health Canada or any regulatory authority for clinical use
Artificial overexpression of GPx1 showed an increased capacity to rescue breast cancer cells from the cell cycle arrest caused by hyperoxic stress, indicating the involvement of both peroxide-derived free radicals and nonperoxide-derived species during the deleterious process [84]
The approval was backed by data from the Phase II TRANSCEND FL study in which treatment with the CAR T cell therapy led to a 95.7% overall response rate, with a complete response rate of 73.4%
US$ 25.07
US$ 22.71
US$ 28.14
US$ 29.25
